Details for New Drug Application (NDA): 210616
✉ Email this page to a colleague
The generic ingredient in KETOROLAC TROMETHAMINE is ketorolac tromethamine; phenylephrine hydrochloride. There are eighteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine; phenylephrine hydrochloride profile page.
Summary for 210616
Tradename: | KETOROLAC TROMETHAMINE |
Applicant: | Chartwell Rx |
Ingredient: | ketorolac tromethamine |
Patents: | 0 |
Pharmacology for NDA: 210616
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 210616
Suppliers and Packaging for NDA: 210616
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
KETOROLAC TROMETHAMINE | ketorolac tromethamine | TABLET;ORAL | 210616 | ANDA | Burel Pharmaceuticals, LLC | 35573-450 | 35573-450-02 | 100 TABLET, FILM COATED in 1 BOTTLE (35573-450-02) |
KETOROLAC TROMETHAMINE | ketorolac tromethamine | TABLET;ORAL | 210616 | ANDA | A-S Medication Solutions | 50090-6265 | 50090-6265-0 | 20 TABLET, FILM COATED in 1 BOTTLE (50090-6265-0) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Aug 16, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription